Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01289678
Recruitment Status : Terminated (Unable to meet accrual goals)
First Posted : February 4, 2011
Last Update Posted : March 8, 2017
Information provided by (Responsible Party):
Leo W. Jenkins Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 31, 2016
  Actual Study Completion Date : August 31, 2016